Why hospitals should look to drug utilization, not price, for continued cost savings

Medication spend represents a major expense for hospitals, especially amid ever-increasing drug prices.

Advertisement

To help protect their bottom line, hospitals must implement cost containment strategies for drug spend. However, standardizing drug products or purchasing cheaper medications do not always offer a long-term solution. Hospitals must also analyze drug utilization to ensure continued cost savings, according to Kathy Chase, PharmD, product leader for the Drug Cost Control Service of Cardinal Health.

During a webinar sponsored by Cardinal Health, Ms. Chase will join Dave Braasch, president of Alton (Ill.) Memorial Hospital, and Susan Samet, director of clinical consultation and operations at Cardinal Health, to share how hospitals can achieve cost savings and improve patient outcomes through drug utilization-focused initiatives.

Tune in to learn how data analysis, combined with a continuous approach to supply costs management, can play a crucial role in achieving these savings.

The webinar is scheduled from noon to 1 p.m. CDT on Wednesday, March 7. To register, click here.

More articles on supply chain:
Teva shutters offices in New York City, Washington D.C., as part of cost cutting plan
Walgreens, AmerisourceBergen reportedly end takeover discussions with no deal
3 latest FDA approvals

 

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Register to Attend Webinar

Beyond the bottleneck: How health systems are improving access, flow and care continuity

Thursday, July 30
1:00 PM - 2:00 PM CDT

Presenters: Imamu Tomlinson, MD, MBA, VituityWilliam Morice II, MD, PhD, Mayo Clinic LaboratoriesJordan Dale, MD, Houston MethodistAsh Tengshe, City of HopeChris Klay, MHA, MA, PT, FACHE, Hospital Sisters Health System

Advertisement

Next Up in Supply Chain

Advertisement

Comments are closed.